001     157827
005     20230915092358.0
024 7 _ |a 10.1002/brb3.2035
|2 doi
024 7 _ |a pmid:33448670
|2 pmid
024 7 _ |a pmc:PMC8119792
|2 pmc
024 7 _ |a altmetric:98807494
|2 altmetric
037 _ _ |a DZNE-2021-01284
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Donix, Markus
|0 P:(DE-2719)2501739
|b 0
|e First author
|u dzne
245 _ _ |a Relation of retinal and hippocampal thickness in patients with amnestic mild cognitive impairment and healthy controls.
260 _ _ |a Malden, Mass.
|c 2021
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1655721871_9506
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a (CC BY)
520 _ _ |a Investigating retinal thickness may complement existing biological markers for dementia and other neurodegenerative diseases. Although retinal thinning is predictive for cognitive decline, it remains to be investigated if and how this feature aligns with neurodegeneration elsewhere in the brain, specifically in early disease stages.Using optical coherence tomography and magnetic resonance imaging, we examined retinal thickness as well as hippocampal structure in patients with amnestic mild cognitive impairment and healthy controls.The groups did not differ in hippocampal and retinal thickness measures. However, we detected a correlation of peripapillary retinal nerve fiber layer thickness and hippocampal thickness in healthy people but not in cognitively impaired patients. The ratio of hippocampus to retina thickness was significantly smaller in patients with mild cognitive impairment and correlated positively with cognitive performance.Different temporal trajectories of neurodegeneration may disrupt transregional brain structure associations in patients with amnestic mild cognitive impairment.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a hippocampus
|2 Other
650 _ 7 |a magnetic resonance imaging
|2 Other
650 _ 7 |a mild cognitive impairment
|2 Other
650 _ 7 |a optical coherence tomography
|2 Other
650 _ 7 |a retina
|2 Other
650 _ 2 |a Alzheimer Disease
|2 MeSH
650 _ 2 |a Brain
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: diagnostic imaging
|2 MeSH
650 _ 2 |a Hippocampus: diagnostic imaging
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Retina: diagnostic imaging
|2 MeSH
650 _ 2 |a Tomography, Optical Coherence
|2 MeSH
700 1 _ |a Wittig, Dierk
|b 1
700 1 _ |a Hermann, Wiebke
|0 P:(DE-2719)2814194
|b 2
|u dzne
700 1 _ |a Haussmann, Robert
|0 P:(DE-2719)9000458
|b 3
|u dzne
700 1 _ |a Dittmer, Maren
|b 4
700 1 _ |a Bienert, Franziska
|b 5
700 1 _ |a Buthut, Maria
|b 6
700 1 _ |a Jacobi, Liane
|b 7
700 1 _ |a Werner, Annett
|0 P:(DE-2719)2812330
|b 8
|u dzne
700 1 _ |a Linn, Jennifer
|b 9
700 1 _ |a Ziemssen, Tjalf
|b 10
700 1 _ |a Brandt, Daniel Moritz
|0 P:(DE-2719)2812107
|b 11
|e Last author
|u dzne
773 _ _ |a 10.1002/brb3.2035
|g Vol. 11, no. 5
|0 PERI:(DE-600)2623587-0
|n 5
|p e02035
|t Brain and behavior
|v 11
|y 2021
|x 2162-3279
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/157827/files/DZNE-2021-01284.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/157827/files/DZNE-2021-01284.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:157827
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2501739
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2814194
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 3
|6 P:(DE-2719)9000458
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2812330
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2812107
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2021
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-01-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-01-27
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-01-27
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRAIN BEHAV : 2021
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-04-16T15:13:12Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-04-16T15:13:12Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-04-16T15:13:12Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-22
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-22
920 1 _ |0 I:(DE-2719)1710012
|k Clinical Study Team Dresden ; AG Falkenburger
|l Clinical Study Team Dresden
|x 0
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research Rostock /Greifswald
|x 1
920 1 _ |0 I:(DE-2719)1710008
|k AG Donix
|l Clinical planning and intersite group
|x 2
920 1 _ |0 I:(DE-2719)1710004
|k AG Karl
|l Retinal Regeneration and Degeneration
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1710012
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a I:(DE-2719)1710008
980 _ _ |a I:(DE-2719)1710004
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21